Fermentation Process Advantages and Financial Highlights

0 The Indian Pharma Advantage 01 Cost Efficiency GB ■ Low cost of production & R&D boosts efficiency of Indian pharma companies, leading to competitive exports ■ India's cost of production is approximately 33 per cent lower than that of the US ■ India's ability to manufacture high-quality, low-priced medicines, leads to huge business opportunity Increasing Investments 02 ▪ Increasing private sector investments in R&D and acquisitions are driving sector's growth ■ Between 2008-19, S&P BSE Healthcare Index has grown at 16.72% 03 ■ Economic prosperity to improve drug affordability Economic Drivers ■ Increasing penetration of health insurance to drive expenditure on medicine ■ With increasing penetration of pharmacies, especially in rural India, OTC drugs will be readily available 04 ■ Pharma Vision 2020' aimed at making India global leader in end-to-end drug manufacturing Policy Support ■ Under Budget 2020-21, allocation to Ministry of Health and Family Welfare is Rs 65,012 Cr (US$ 9.30 billion) ■ In this sector, 100 per cent FDI allowed under automatic route Indian pharmaceutical sector expected to cross to US$ 372 billion In February 2020, Indian pharmaceutical sales grew by 12.1 % year-on-year Source: https://www.ibef.org/industry/pharmaceutical-india.aspx https://www.ibef.org/download/Pharmaceuticals-May-2020.pdf Annual Turnover of Indian Pharmaceutical Market (US$ billion) 20.03 17.87 18.12 16.41 2016 2017 2018 2019 15

View entire presentation